Ignite Creation Date:
2024-05-06 @ 10:35 AM
Last Modification Date:
2024-10-26 @ 12:32 PM
Study NCT ID:
NCT03303339
Status:
COMPLETED
Last Update Posted:
2023-02-27
First Post:
2017-09-06
Brief Title:
Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia AML
Sponsor:
Cardiff Oncology
Organization:
Cardiff Oncology
Organization Data
Organization:
Cardiff Oncology
Class:
INDUSTRY
Study ID:
TROV-052
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cardiff Oncology
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None